Sector: Pharmaceuticals & Biotechnology

Small Cap

Welcure Drugs Share Price

Q: What is the Market Capitalization of Welcure Drugs & Pharmaceuticals Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Welcure Drugs & Pharmaceuticals Ltd. is approximately ₹ 35.8 Cr.

Q: What are the PE and PB ratios for Welcure Drugs & Pharmaceuticals Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Welcure Drugs & Pharmaceuticals Ltd. is 1, and the Price-to-Book (PB) ratio is 0.2.

Q: What is the 52-Week High and Low for Welcure Drugs & Pharmaceuticals Ltd.?

Over the past 52 weeks, the highest price reached by Welcure Drugs & Pharmaceuticals Ltd. shares was ₹ 1.44, and the lowest price was ₹ 0.23.

Q: Who are the peers of Welcure Drugs & Pharmaceuticals Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Welcure Drugs & Pharmaceuticals Ltd. is often compared with other major players such as Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda, Rekvina Laboratories and Vivimed Labs for analysis and benchmarking.

Welcure Drugs & Pharmaceuticals Ltd.

₹0.29

0.00(0.00%)

Trade Now

25th May 2026 | 3:28 PM

NSE :

Open Free Demat Account

Welcure Drugs Performance

Price Movement

N/A

₹0.29

₹0.30

↘ Today's Low↗ Today's High

1 Year Performance

Data is not available

Markets Today

High₹0.30

Low₹0.29

Open at₹0.29

Prev Close₹0.29

Volumes62.41 L

Avg Price₹0.29

Lower Circuit₹0.28

Upper Circuit₹0.30

Historical Performance

3M High₹0.36

3M Low₹0.23

1 Yr High₹1.44

1 Yr Low₹0.23

3 Yr High₹1.44

3 Yr Low₹0.23

5 Yr High₹1.44

5 Yr Low₹0.23

Welcure Drugs Fundamentals

Market Cap

Low in industry

35.80 Cr.

PE Ratio (TTM)

Low in industry

Dividend Yield

Net Profit TTM

1773.5% incr over last year

35.41

Net Profit Growth

1773.5% incr over last year

35.41

PEG Ratio

Below industry Median

ROE

116.3% incr over last year

2.11

Operating Revenue TTM

386.75

Operating Revenue Growth

1058.3% incr over last year

Book Value

Low in industry

0.20

MFI

MFI is mid-range

39.28

RSI

RSI is mid-range

EPS (TTM)

-1.46

Debt to Equity

-2.97

Face Value

Operating Profit Margin Qtr.

-119.40

Operating Profit Qtr.

Net Profit Qtr.

Operating Revenue Qtr.

PB Ratio

0.20

Welcure Drugs Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024
Total Revenue	0	65.62	299.91	21.21	8.84
Operating Expense	0.03	54.25	268.77	20.58	7.92
Operating Profit	-0.03	11.37	31.14	0.64	0.92
Depreciation	0	0	0	0.01	0
Interest	0	0	0	0	0
Tax	0.36	2.86	7.84	0	0.50
Net Profit	1.07	8.50	23.30	2.54	0.41

Welcure Drugs Technicals

Welcure Drugs & Pharmaceuticals Ltd. EMA & SMA

₹0.29

0.00 (0.00%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹0.3

Day EMA10 ₹0.3

Day EMA12 ₹0.3

Day EMA20 ₹0.3

Day EMA26 ₹0.3

Day EMA50 ₹0.3

Day EMA100 ₹0.4

Day EMA200 ₹0.5

Welcure Drugs Support and Resistance

Resistance

First Resistance₹0.30

Second Resistance₹0.30

Third Resistance₹0.31

Support

First Support₹0.29

Second Support₹0.28

Third Support₹0.28

Technical Indicators

Day RSI49.00

Day MFI39.28

Day ADX19.04

Day Commodity Channel Index27.40

William-40.00

Day MACD-

Day MACD Signal Line-

Day ATR0.01

Day ROC125-46.30

Day ROC21-6.45

Welcure Drugs Shareholding Pattern

Held By

Welcure Drugs Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	24.81 L	58.59 L	42.35%
Week	28.99 L	57.36 L	50.54%
1 Month	35.36 L	68.55 L	51.58%
6 Month	58.29 L	1.17 Cr	49.66%

Welcure Drugs SWOT Analysis

Strengths10

Weakness10

Opportunity0

Threats0

Companies with current TTM PE Ratio less than 3 Year, 5 Year and 10 Year PE

Undervalued Growth Stocks

Companies with high TTM EPS Growth

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

Affordable Stocks - Stocks with Good Valuation Score

Companies with Net Profit TTM 5X that of Net Profit in Previous Year

Company able to generate Net Cash - Improving Net Cash Flow for last 2 years

Companies with Zero Promoter Pledge

Stock with Low PE (PE < = 10)

Welcure Drugs Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
No Record Found

Welcure Drugs Stock Comparison

Financials	Goldline Pharmaceutical Ltd.	Sai Parenterals Ltd.	Speciality Medicines Ltd.	Accretion Nutraveda Ltd.	Rekvina Laboratories Ltd.	Vivimed Labs Ltd.
Price (₹)	₹46.26	₹492.90	₹219.30	₹252.10	₹38.27	₹6.40
% Change	-4.99%	1.27%	4.95%	-4.14%	4.99%	-2.14%
Revenue TTM (₹ Cr)	-	-	-	-	₹1.27	₹83.60
Net Profit TTM (₹ Cr)	-	-	-	-	₹-0.25	₹-34.95
PE TTM	15.70	-	22.40	36.00	-90.60	-1.50
1 Year Return		24.95			750.44	544
ROCE	-	3.56	-	-	-	-5.63

Similar Stocks

APPL

Aptus Pharma Ltd.

₹ 179.50

-1.37%

AMANTA

Amanta Healthcare Ltd.

₹ 131.01

+0.71%

AHCL

Anlon Healthcare Ltd.

₹ 13.79

-0.86%

PATELCHEM

Patel Chem Specialities Ltd.

₹ 87.00

-4.05%

APL

Asston Pharmaceuticals Ltd.

₹ 72.80

+0.00%

AMRUTANJAN

Amrutanjan Health Care Ltd.

₹ 559.75

+0.46%

ASTONEALAB

Astonea Labs Ltd.

₹ 231.00

+1.76%

AMWILL

Amwill Health Care Ltd.

₹ 32.38

+4.96%

INNOVACAP

Innova Captab Ltd.

₹ 852.80

+0.53%

VALIANTLAB

Valiant Laboratories Ltd.

₹ 78.00

+1.46%

SHELTER

Shelter Pharma Ltd.

₹ 30.63

-0.07%

TLL

Trident Lifeline Ltd.

₹ 254.00

+2.13%

DPL

Dipna Pharmachem Ltd.

₹ 7.47

-0.66%

ACHYUT

Achyut Healthcare Ltd.

₹ 5.83

+2.64%

SIGACHI

Sigachi Industries Ltd.

₹ 20.34

-0.05%

WINDLAS

Windlas Biotech Ltd.

₹ 784.40

-0.70%

VINEETLAB

Vineet Laboratories Ltd.

₹ 35.00

-1.69%

CBPL

Chandra Bhagat Pharma Ltd.

₹ 40.00

+5.26%

SOLARA

Solara Active Pharma Sciences Ltd.

₹ 556.00

+1.44%

RAJNISH

Rajnish Wellness Ltd.

₹ 0.45

+0.00%

ZIMLAB

Zim Laboratories Ltd.

₹ 99.45

-0.71%

BPLPHARMA

Bharat Parenterals Ltd.

₹ 1374.35

-0.69%

MEDICO

Medico Remedies Ltd.

₹ 48.93

+2.28%

FAQ's on WELCURE

What is the Market Capitalization of Welcure Drugs & Pharmaceuticals Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Welcure Drugs & Pharmaceuticals Ltd. is approximately ₹ 35.8 Cr.

What are the PE and PB ratios for Welcure Drugs & Pharmaceuticals Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Welcure Drugs & Pharmaceuticals Ltd. is 1, and the Price-to-Book (PB) ratio is 0.2.

What is the 52-Week High and Low for Welcure Drugs & Pharmaceuticals Ltd.?

Over the past 52 weeks, the highest price reached by Welcure Drugs & Pharmaceuticals Ltd. shares was ₹ 1.44, and the lowest price was ₹ 0.23.

Who are the peers of Welcure Drugs & Pharmaceuticals Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Welcure Drugs & Pharmaceuticals Ltd. is often compared with other major players such as Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda, Rekvina Laboratories and Vivimed Labs for analysis and benchmarking.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy